Thyroid diseases limits

Adapted from Jacobson3, Cooper and Stroehla4 thyroid disease prevalence data from HollowellS and includes clinical and subclinical disease limited to clinical disease estimates are 500 per... 

Iodoquinol should be taken with meals to limit gastrointestinal toxicity. It should be used with caution in patients with optic neuropathy, renal or thyroid disease, or nonamebic hepatic disease. The drug should be discontinued if it produces persistent diarrhea or signs of iodine toxicity (dermatitis, urticaria, pruritus, fever). It is contraindicated in patients with intolerance to iodine. 

People with exposure to anti-thyroid drugs (e.g., lithium), thyroid disease, or otherwise compromised thyroid function might have a more pronounced response to PBBs and PBDEs because of their underlying limitations in thyroid hormone production. Similarly, people with compromised function of other organs, such as those with liver or kidney diseases (e g., liver cirrhosis or hepatitis B), could be considered more susceptible to health effects of PBBs and PBDEs. 

Takatera and Watanabe [41] used this technique for the speciation of iodide ion, I-, and five iodo amino acids (monoiodotyrosine (MIT), diiodotyrosine (DIT), 3,3,5-triiodothyromine (T3), 3,3,5 -triiodothyromine (rT3), and thyroxine (T4)) which are all found in thyroid hormones. The speciation of these compounds in clinical samples such as blood plasma and urine may assist in the identification of thyroid diseases. The RPLC-ICP-MS system was able to detect all of the I-containing compounds with no interferences. Detection limits were in the range 35-130 pg for the six compounds using a 50% methanol eluent. Detection limits were better for species eluted at a shorter retention time since the peak shapes were sharper. The detection limits calculated were an order of magnitude lower than for methods where UV absorbance detection was used. 

Myalgias related to statin use are quite common, occurring in up to 10 % of patients exposed [19]. Clinicians often measure circulating levels of nonspecific markers of myocyte damage (e.g., CK) to estimate severity. Myalgias accompanied by a mild elevation in serum CK level occur in approximately 1 % of patients exposed [20, 21], Myopathy (CK >10-fold upper limit of normal) is less common, 0.1 %, and rhabdomyolysis (CK >50-fold upper limit of normal) is extremely rare [14, 15]. Graham and colleagues surveyed more than 250,000 statin-exposed patients, and reported rhabdomyolysis rates of 0.000044 events per person-year [18]. Similar rates have been observed for more than 100,000 first-time statin users followed in the UK over a course of 20 months [22], Event rates increase when statins are used in the presence of other medications known to alter their absorption, distribution, metabolism, and elimination (ADME) [23, 24], Event rates also increase with comorbidity (e.g., thyroid disease) [21, 25]. 

The beneficial effects of iodine supplementation in the prevention and control of developed thyroid abnormalities due to iodine deficiency have been discussed so far in this chapter. However, supplementation with excess iodine, including the improvement of a previous iodine-deficient state, may cause thyroid dysfunctions, viz., iodine-induced hypothyroidism/iodide goiter in susceptible subjects (Roti and Vagenakis, 2000) and iodine-induced hyperthyroidism (IIH) especially in individuals over 40 years of age and who have been iodine deficient for a long period in the past (Vidor et ai, 1973). It may also increase the ratio of papillary/follicular carcinomas (Slowinska-Klencka et ai, 2002). In other words, both low and excess intake of iodine is related to further risk of thyroid disease. Although a daily intake of up to 1000 pg/day by a normal adult individual is quite safe (WHO, 1994), the upper limit is much lower in a population that has been exposed to iodine deficiency in the past. Therefore, to prevent IDD, the recommended iodine requirement in an adult individual is fixed within a narrow range of 150 rg/day (Knudsen et ai, 2000). Iodine supplementation under certain conditions in certain populations causes adverse effects, e.g., iodide goiter and iodine-induced hypothyroidism, IIH, iodine-induced thyroiditis and thyroid cancer. 

Clarke, J.U. (1998). Evaluation of censored data methods to allow statistical comparisons among very small samples with below detection limits observations. Environmental Science Technology. Vol. 32, pp. 177-183. ISSN 1520-5851 Cole, R.A. Phelps, K. (1979). Use of canonical variate analysis in the differentiation of swede cultivars by gas-liquid chromatography of volatile hydrolysis products. Journal of the Science of Food and Agriculture. Vol. 30, pp. 669-676. ISSN 1097-0010 Coomans, D. Broeckaert, L Fonckheer, M Massart, D.L. Blocks, P. (1978). The application of linear discriminant analysis in the diagnosis of thyroid diseases. Analytica Chimica Acta. Vol. 103, pp. 409-415. ISSN 0003-2670 Coomans, D. Massart, D.L. Kaufman, L. (1979) Optimization by statistical linear discriminant analysis in analytical chemistry. Analytica Chimica Acta. Vol. 112, pp. 97-122. ISSN 0003-2670... 

In June 1987, 14 months after the disaster, some 27 villages within the restricted zone were still heavily contaminated, because the cleanup operation had stopped. Nearby cities and towns were reporting dramatic rises in thyroid diseases, anemia, and cancer. Hardest hit were children. Frequently, calves were bom without heads, eyes, or limbs. The three remaining nuclear reactors were still mnning, and two new reactors were under constmction. Despite ambient radiation levels 9 times higher than widely accepted limits, woikers at the power-plant were living in newly built colonies inside the dead zone. ... 

In subacute thyroiditis, thyroid function tests typically run a triphasic course in this self-limited disease. Initially, serum T4 levels are elevated due to release of preformed thyroid hormone from disrupted follicles. The 24-hour RAIU during this time is less than 2% because of thyroid inflammation and TSH suppression by the elevated T4 level. As the disease progresses, intrathyroidal hormone stores are depleted, and the patient may become mildly hypothyroid with an appropriately elevated TSH level. During the recovery phase, thyroid hormone stores are replenished and serum TSH elevation gradually returns to normal. 

Treatments for autoimmune disease have traditionally been immunosuppressive, antiinflammatory or palliative. Non-immunological therapies, such as hormone replacement in Hashimoto s thyroiditis, treat the outcomes of the autoaggressive response. Dietary manipulation limits the severity of coeliac disease. Steroidal or NSAID treatment limits the inflammatory symptoms of many diseases. 

The enzyme TPO is now recognized as the principal and possibly only autoantigenic component of thyroid micro-somes. Assays based on TPO itself are preferred for routine clinical use in the management of patients with suspected autoimmune disease of the thyroid. Performance of anti-microsomal antibody assays is complicated by the limited availability of human thyroid tissue, the presence of irrelevant thyroid antigens and autoantibodies, and the contamination of microsome preparations with Tg. These complications seem to have been ehminated by using TPO as the antigen. 

The feedback hypothesis would suggest that TSH levels would be decreased or absent in hyperthyroidism unless hyperthyroidism is caused by excess TSH secretion. Reports conflict as to whether or not TSH blood levels are increased in Graves disease. Much of the conflict arises from the fact that the earlier reports may not have taken LATS into account. Most recent studies suggest that TSH levels are not elevated in hyperthyroidism (Table 1). Since no assay to date is sensitive enough to establish a lower limit of normal for TSH in blood, it has not been possible to determine whether TSH was absent in the blood of patients with hyperthyroidism. The finding that TSH levels are at least normal in hyperthyroidism is important evidence that TSH itself is not the cause of thyroid overactivity. 

---